Loading...
XASX
HCT
Market cap11mUSD
Oct 09, Last price  
0.05AUD
1Q
-37.50%
IPO
-96.98%
Name

Holista CollTech Ltd

Chart & performance

D1W1MN
XASX:HCT chart
P/E
—
P/S
3.19
EPS
—
Div yield, %
—
Shrs. gr., 5y
6.30%
Rev. gr., 5y
-4.10%
Revenues
6m
+2.96%
28,17037,5539,2006,250,0006,077,0005,440,0005,199,0056,178,4047,060,2806,263,6718,008,3887,846,8818,042,7977,257,7787,106,6358,023,1298,241,2255,946,9095,598,2395,764,055
Net income
-949k
L+1,026.80%
-2,788,392-1,884,598-1,919,671-1,573,000-804,000-536,000-1,600,700-3,280,82233,488-407,930332,536-3,030,290-1,612,147-689,851-5,483,167-1,256,209-1,452,902-4,805,763-84,214-948,921
CFO
-1m
L+32.82%
-2,597,371-2,030,992-1,235,793-1,981,000-79,000-265,815-328,145-276,092-4,233394,7441,378,416240,922-2,200,266-160,975-3,867,610-1,676,068-1,111,444-407,121-1,013,744-1,346,441

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Holista CollTech Limited is a biotechnology firm with operations spanning Australia, Malaysia, and the United States. Its business activities are organized into four key divisions: Supplements, Ovine Collagen, Infection Control Solutions, and Food Ingredients. The company specializes in the production and distribution of dietary supplements, cosmetic-quality collagen, and a variety of health-conscious food ingredients. These innovative food products include low-glycemic index (GI) flour blends suitable for noodles, pasta, flatbreads, and other baked goods, along with low-sodium salt, reduced-fat fried options, and both less-calorie and low-GI sugar alternatives. Furthermore, Holista CollTech offers solutions for infection control. Its corporate headquarters are located in Subiaco, Australia.

Key people

Lai Kwok Kin
Independent Non-Executive Chairman of the Board · since 2025
Hon Khien Kong
Chief Financial Officer · since 2011
Man Loong Leong
Interim Chief Executive Officer, Executive Director · since 2025
Company Secretary · since 2021
Loren King
Non-Executive Director · since 2021
Gregory Pilant
Non-Executive Director · since 2025
Robert Gemelli
Non-Executive Independent Director · since 2025
Yuen Keong Yee
Non-Executive Independent Director · since 2025
IPO date
Feb 26, 2004
Employees
3
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT